Effect of MRI white matter hyperintensities over L-Dopa response in patients with idiopathic Parkinson's disease

被引：0
|
作者：
Arena, J. E.
Ballesteros, D.
Cerquetti, D.
Dossi, D. E.
Rossi, M. D.
Chaves, H.
Rollan, C.
Melli, F.
Merello, M.
机构：
来源：
MOVEMENT DISORDERS | 2014年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
345
引用
收藏
页码：S134 / S134
页数：1
相关论文
共 50 条
  • [21] The effect of L-dopa on visuospatial analysis in patients with Parkinson's disease with motor fluctuations
    Balash, Y
    Schaafsma, J
    Bartels, A
    Giladi, N
    MOVEMENT DISORDERS, 2002, 17 : S75 - S75
  • [22] The effects of different repeated doses of entacapone on the pharmacokinetics of L-Dopa and on the clinical response to L-Dopa in Parkinson's disease
    Heikkinen, H
    Nutt, JG
    LeWitt, PA
    Koller, WC
    Gordin, A
    CLINICAL NEUROPHARMACOLOGY, 2001, 24 (03) : 150 - 157
  • [23] Pupillometry as an indicator of l-DOPA dosages in Parkinson’s disease patients
    O. Bartošová
    C. Bonnet
    O. Ulmanová
    M. Šíma
    F. Perlík
    E. Růžička
    O. Slanař
    Journal of Neural Transmission, 2018, 125 : 699 - 703
  • [24] Pupillometry as an indicator of L-DOPA dosages in Parkinson's disease patients
    Bartosova, O.
    Bonnet, C.
    Ulmanova, O.
    Sima, M.
    Perlik, F.
    Ruzicka, E.
    Slanar, O.
    JOURNAL OF NEURAL TRANSMISSION, 2018, 125 (04) : 699 - 703
  • [25] Effect of L-dopa on explicit sequence learning in Parkinson's disease
    Ghilardi, M.
    Fegin, A.
    Battaglia, F.
    Mattis, P.
    Eidelberg, D.
    Di Rocco, A.
    MOVEMENT DISORDERS, 2006, 21 : S653 - S654
  • [26] Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease
    Pawlukowska, Wioletta
    Golab-Janowska, Monika
    Safranow, Krzysztof
    Rotter, Iwona
    Amernik, Katarzyna
    Honczarenko, Krystyna
    Nowacki, Przemystaw
    NEUROLOGIA I NEUROCHIRURGIA POLSKA, 2015, 49 (05) : 302 - 306
  • [27] Peculiarities of L-DOPA treatment of Parkinson’s disease
    R. M. Kostrzewa
    P. Nowak
    J. P. Kostrzewa
    R. A. Kostrzewa
    R. Brus
    Amino Acids, 2005, 28 : 157 - 164
  • [28] Monitoring of L-dopa concentrations in Parkinson's disease
    Furlanut, M
    Furlanut, M
    Benetello, P
    PHARMACOLOGICAL RESEARCH, 2001, 43 (05) : 423 - 427
  • [29] L-dopa induced dyskinesia in Parkinson's disease
    Bastide, Matthieu F.
    Bezard, Erwan
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2015, 199 (2-3): : 201 - 212
  • [30] Variation in the L-dopa motor response in pathologically confirmed Parkinson's disease
    Pitz, V.
    Malek, N.
    Grosset, K.
    Grosset, D.
    MOVEMENT DISORDERS, 2018, 33 : S104 - S105
12345